October 22, 2009 (Atlanta, Georgia) — An oral contraceptive (OC) consisting of estradiol valerate/dienogest (E2V/DNG) appears to be effective in resolving abnormal menstrual symptoms in patients ...
A joint study by the University of Oulu and University of Helsinki, Finland, compared the effects of two different types of estrogen in combined contraceptives (COCs) on blood inflammatory markers and ...
A new oral contraceptive providing the same estrogen produced by the female body Berlin, October 16, 2008 - Bayer Schering Pharma AG has successfully completed the decentralized drug approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results